IO Biotech, Inc.
IOBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $849 | $756 | $540 | $0 |
| Gross Profit | -$849 | -$756 | -$540 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $71,484 | $67,829 | $46,986 | $30,152 |
| G&A Expenses | $0 | $0 | $0 | $11,082 |
| SG&A Expenses | $22,844 | $22,858 | $23,898 | $11,082 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $94,328 | $90,687 | $70,884 | $41,234 |
| Operating Income | -$95,177 | -$91,443 | -$71,424 | -$41,234 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,129 | $6,212 | $1,239 | -$26,577 |
| Pre-Tax Income | -$94,048 | -$85,231 | -$70,185 | -$67,811 |
| Tax Expense | $1,443 | $852 | $1,273 | $68 |
| Net Income | -$95,491 | -$86,083 | -$71,458 | -$67,879 |
| % Margin | – | – | – | – |
| EPS | -1.45 | -1.98 | -2.48 | -2.36 |
| % Growth | 26.8% | 20.2% | -5.1% | – |
| EPS Diluted | -1.45 | -1.98 | -2.48 | -2.36 |
| Weighted Avg Shares Out | 65,881 | 43,539 | 28,815 | 28,815 |
| Weighted Avg Shares Out Dil | 65,881 | 43,540 | 28,815 | 28,815 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,718 | $5,881 | $1,411 | $0 |
| Interest Expense | $0 | $0 | $302 | $361 |
| Depreciation & Amortization | $849 | $756 | $540 | $2 |
| EBITDA | -$93,199 | -$84,475 | -$69,343 | -$67,448 |
| % Margin | – | – | – | – |